Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Endothelin-1 and cardiovascular diseases].

J L Cracowski1, F Stanke, G Bessard

  • 1Laboratoire de pharmacologie, PCEBM, faculté de médecine, La Tronche, France.

La Revue De Medecine Interne
|August 6, 1999
PubMed
Summary

Endothelin-1, a peptide from endothelial cells, impacts blood pressure and vascular tone. Endothelin receptor antagonists show promise for treating cardiovascular diseases like hypertension and heart failure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Skin transient receptor potential channels expression and microvascular reactivity to cooling in primary and secondary Raynaud's phenomenon.

Physiological reports·2025
Same author

Signal detection of drugs associated with obstructive and central sleep apnoea.

Sleep medicine·2024
Same author

Learning condyle repositioning during orthognathic surgery with a surgical navigation system.

International journal of oral and maxillofacial surgery·2019
Same author

Skin biomechanical properties in patients with systemic sclerosis: what parameter should be used?

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Abnormal amplitude and kinetics of digital postocclusive reactive hyperemia in systemic sclerosis.

Microvascular research·2014
Same author

The digital thermal hyperemia pattern is associated with the onset of digital ulcerations in systemic sclerosis during 3 years of follow-up.

Microvascular research·2014

Area of Science:

  • Biochemistry
  • Physiology

Context:

  • Endothelins are peptides from endothelial cells.
  • Endothelin-1 regulates vascular tone and blood pressure.
  • Associated with vasoconstriction and vascular hypertrophy in diseases.

Purpose:

  • To explore the role of endothelin-1 in cardiovascular regulation.
  • To evaluate the therapeutic potential of endothelin receptor antagonists.

Summary:

  • Endothelin-1 binds to ETA, ETB2, and ETB1 receptors, influencing vascular smooth muscle contraction and relaxation.
  • ETA and ETB2 receptor stimulation cause contraction and proliferation, while ETB1 stimulation causes relaxation.
  • Endothelin receptor antagonists are emerging as treatments for conditions like heart failure and hypertension.

Impact:

  • Endothelin receptor antagonists offer a novel therapeutic strategy for cardiovascular diseases.
  • Further long-term studies are needed to confirm efficacy in heart failure, systemic hypertension, ischemic heart disease, and pulmonary hypertension.

Related Experiment Videos